Deaglan McHugh Selected Research

ASG-5ME

10/2019

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deaglan McHugh Research Topics

Disease

2	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 10/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Pain (Aches) 10/2021
1	Diarrhea 10/2019
1	Exanthema (Rash) 10/2019
1	Fatigue 10/2019
1	Hyponatremia 10/2019
1	Abdominal Pain (Pain, Abdominal) 10/2019
1	Neutropenia 10/2019
1	Hypoxia (Hypoxemia) 10/2019
1	Constipation 10/2019

Drug/Important Bio-Agent (IBA)

1	atezolizumabIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 10/2021
1	Radium-223IBA 10/2021
1	auristatinIBA 10/2019
1	ASG-5MEIBA 10/2019
1	monomethyl auristatin EIBA 10/2019
1	TroponinIBA 10/2019
1	Immunoconjugates (Immunoconjugate)IBA 10/2019

Therapy/Procedure

2	Castration 10/2021 - 10/2019
1	Cystectomy 01/2022